PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Wykoff, Charles C.
TI  - Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment
DP  - 2014  01
TA  - MD Conference Express
PG  - 7--8
VI  - 14
IP  - 43
4099  - http://mdc.sagepub.com/content/14/43/7.short
4100  - http://mdc.sagepub.com/content/14/43/7.full
AB  - This article presents data from the open-label extension study of the RIDE [A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus; NCT00473382] and RISE [A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus; NCT00473330] trials.